For citations:
Revkova M.A., Krinitsina A.A., Nemtsova M.V., Makarova M.V., Chernevskiy D.K., Sagaydak O.V., Mikhailov V.S., Ulanova P.V., Tsukanov A.S., Byakhova M.M., Semenova A.B., Galkin V.N., Babajanova Ch.V., Danishevich A.M., Bodunova N.A., Gadzhieva S.M., Belinikin M.S. Validation of PMS2 germline variants in patients with hereditary cancer syndromes. Medical Genetics. 2024;23(2):34-45. (In Russ.) https://doi.org/10.25557/2073-7998.2024.02.34-45
Email this article 